Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Oct;39(10):2187–2192. doi: 10.1128/aac.39.10.2187

Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.

K Nagata 1, E Takagi 1, H Satoh 1, H Okamura 1, T Tamura 1
PMCID: PMC162911  PMID: 8619564

Abstract

The proton pump inhibitors (PPIs) omeprazole and lansoprazole and the acid-activated analog of lansoprazole AG-2000, which potently inhibit the urease of Helicobacter pylori (K. Nagata, H. Satoh, T. Iwahi, T. Shimoyama, and T. Tamura, Antimicrob. Agents Chemother. 37:769-774, 1993), also inhibited the urease activities of cell-free extracts as well as intact cells of Ureaplasma urealyticum. The 50% inhibitory concentrations were between 1 and 25 microM. These compounds also inhibited the ATP synthesis induced by urea in ureaplasma cells. The 50% inhibitory concentrations for ATP synthesis were close to those for urease activity, but they were lower than those of urease inhibitors, such as acetohydroxamic acid, hydroxyurea, and thiourea. In addition, one of the metabolites of lansoprazole found in human urine, M-VI, also inhibited ureaplasmal urease activity and the ATP synthesis induced by urea at almost the same concentrations as those of lansoprazole. The inhibition of PPIs against ureaplasma urease was very similar to those against H. pylori urease, suggesting that the inhibitory mechanism against these ureases was due to the blockage of the SH residues on the cysteine of the enzyme. Omeprazole, lansoprazole, AG-2000, and M-VI inhibited the growth of U. urealyticum. Since ureaplasma urease is thought to be involved in the pathogenicity of this organism in the urogenital tract, PPIs and their analogs may be useful as chemotherapeutic agents against diseases caused by U. urealyticum.

Full Text

The Full Text of this article is available as a PDF (221.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki I., Okumura M., Yashiki T. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. J Chromatogr. 1991 Nov 15;571(1-2):283–290. doi: 10.1016/0378-4347(91)80457-n. [DOI] [PubMed] [Google Scholar]
  2. Blanchard A., Razin S., Kenny G. E., Barile M. F. Characteristics of Ureaplasma urealyticum urease. J Bacteriol. 1988 Jun;170(6):2692–2697. doi: 10.1128/jb.170.6.2692-2697.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blanchard A. Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon. Mol Microbiol. 1990 Apr;4(4):669–676. doi: 10.1111/j.1365-2958.1990.tb00636.x. [DOI] [PubMed] [Google Scholar]
  4. Cassell G. H., Cole B. C. Mycoplasmas as agents of human disease. N Engl J Med. 1981 Jan 8;304(2):80–89. doi: 10.1056/NEJM198101083040204. [DOI] [PubMed] [Google Scholar]
  5. Cassell G. H., Waites K. B., Crouse D. T., Rudd P. T., Canupp K. C., Stagno S., Cutter G. R. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988 Jul 30;2(8605):240–245. doi: 10.1016/s0140-6736(88)92536-6. [DOI] [PubMed] [Google Scholar]
  6. Cassell G. H., Waites K. B., Watson H. L., Crouse D. T., Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev. 1993 Jan;6(1):69–87. doi: 10.1128/cmr.6.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Collins C. M., D'Orazio S. E. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol Microbiol. 1993 Sep;9(5):907–913. doi: 10.1111/j.1365-2958.1993.tb01220.x. [DOI] [PubMed] [Google Scholar]
  8. Embree J. E., Embil J. A. Mycoplasmas in diseases of humans. Can Med Assoc J. 1980 Jul 19;123(2):105–111. [PMC free article] [PubMed] [Google Scholar]
  9. Ford D. K., MacDonald J. Influence of urea on the growth of T-strain mycoplasmas. J Bacteriol. 1967 May;93(5):1509–1512. doi: 10.1128/jb.93.5.1509-1512.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Friedlander A. M., Braude A. I. Production of bladder stones by human T mycoplasmas. Nature. 1974 Jan 4;247(5435):67–69. doi: 10.1038/247067b0. [DOI] [PubMed] [Google Scholar]
  11. Grenabo L., Hedelin H., Pettersson S. Urinary infection stones caused by Ureaplasma urealyticum: a review. Scand J Infect Dis Suppl. 1988;53:46–49. [PubMed] [Google Scholar]
  12. Iwahi T., Satoh H., Nakao M., Iwasaki T., Yamazaki T., Kubo K., Tamura T., Imada A. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother. 1991 Mar;35(3):490–496. doi: 10.1128/aac.35.3.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kenny G. E., Cartwright F. D. Effect of urea concentration on growth of Ureaplasma urealyticum (T-strain mycoplasma). J Bacteriol. 1977 Oct;132(1):144–150. doi: 10.1128/jb.132.1.144-150.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kenny G. E. Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide. Yale J Biol Med. 1983 Sep-Dec;56(5-6):717–722. [PMC free article] [PubMed] [Google Scholar]
  15. Labigne A., Cussac V., Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol. 1991 Mar;173(6):1920–1931. doi: 10.1128/jb.173.6.1920-1931.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lindberg P., Nordberg P., Alminger T., Brändström A., Wallmark B. The mechanism of action of the gastric acid secretion inhibitor omeprazole. J Med Chem. 1986 Aug;29(8):1327–1329. doi: 10.1021/jm00158a001. [DOI] [PubMed] [Google Scholar]
  17. Masover G. K., Benson J. R., Hayflick L. Growth of T-strain mycoplasmas in medium without added urea: effect of trace amounts of urea and of a urease inhibitor. J Bacteriol. 1974 Feb;117(2):765–774. doi: 10.1128/jb.117.2.765-774.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Masover G. K., Razin S., Hayflick L. Localization of enzymes in Ureaplasma urealyticum (T-strain mycoplasma). J Bacteriol. 1977 Apr;130(1):297–302. doi: 10.1128/jb.130.1.297-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Masover G. K., Sawyer J. E., Hayflick L. Urea-hydrolyzing activity of a T-strain mycoplasma: Ureaplasma urealyticum. J Bacteriol. 1976 Feb;125(2):581–587. doi: 10.1128/jb.125.2.581-587.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mulrooney S. B., Hausinger R. P. Sequence of the Klebsiella aerogenes urease genes and evidence for accessory proteins facilitating nickel incorporation. J Bacteriol. 1990 Oct;172(10):5837–5843. doi: 10.1128/jb.172.10.5837-5843.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nagata K., Satoh H., Iwahi T., Shimoyama T., Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother. 1993 Apr;37(4):769–774. doi: 10.1128/aac.37.4.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nagaya H., Satoh H., Kubo K., Maki Y. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther. 1989 Feb;248(2):799–805. [PubMed] [Google Scholar]
  23. Purcell R. H., Taylor-Robinson D., Wong D., Chanock R. M. Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol. 1966 Jul;92(1):6–12. doi: 10.1128/jb.92.1.6-12.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Romano N., La Licata R. Cell fractions and enzymatic activities of Ureaplasma urealyticum. J Bacteriol. 1978 Dec;136(3):833–838. doi: 10.1128/jb.136.3.833-838.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Romano N., Russo Alesi D., La Licata R., Tolone G. Effects of urea phosphate, ammonium ions and pH on Ureaplasma ATP synthesis. Microbiologica. 1986 Oct;9(4):405–413. [PubMed] [Google Scholar]
  26. Romano N., Tolone G., Ajello F., La Licata R. Adenosine 5'-triphosphate synthesis induced by urea hydrolysis in Ureaplasma urealyticum. J Bacteriol. 1980 Nov;144(2):830–832. doi: 10.1128/jb.144.2.830-832.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Romano N., Tolone G., La Licata R. Adenosine triphosphatase activity of Ureaplasma urealyticum. Microbiologica. 1982 Jan;5(1):25–33. [PubMed] [Google Scholar]
  28. SHEPARD M. C., LUNCEFORD C. D. EFFECT OF PH ON HUMAN MYCOPLASMA STRAINS. J Bacteriol. 1965 Feb;89:265–270. doi: 10.1128/jb.89.2.265-270.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shepard M. C., Lunceford C. D. Occurrence of urease in T strains of Mycoplasma. J Bacteriol. 1967 May;93(5):1513–1520. doi: 10.1128/jb.93.5.1513-1520.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith D. G., Russell W. C., Ingledew W. J., Thirkell D. Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis. J Bacteriol. 1993 Jun;175(11):3253–3258. doi: 10.1128/jb.175.11.3253-3258.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sriwanthana B., Mobley H. L. Proteus mirabilis urease: histidine 320 of UreC is essential for urea hydrolysis and nickel ion binding within the native enzyme. Infect Immun. 1993 Jun;61(6):2570–2577. doi: 10.1128/iai.61.6.2570-2577.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Takebe S., Numata A., Kobashi K. Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors. J Clin Microbiol. 1984 Nov;20(5):869–873. doi: 10.1128/jcm.20.5.869-873.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Taylor-Robinson D. Pathogenicity of ureaplasmas for animals and man. Zentralbl Bakteriol Orig A. 1979 Oct;245(1-2):150–163. [PubMed] [Google Scholar]
  34. Thirkell D., Myles A. D., Precious B. L., Frost J. S., Woodall J. C., Burdon M. G., Russell W. C. The urease of Ureaplasma urealyticum. J Gen Microbiol. 1989 Feb;135(Pt 2):315–323. doi: 10.1099/00221287-135-2-315. [DOI] [PubMed] [Google Scholar]
  35. Ureaplasmas of humans: with emphasis upon maternal and neonatal infections. Proceedings of an international symposium of the International Organization for Mycoplasmology. Seattle, Washington, October 10-12, 1985. Tribute to Dr. Maurice Charles Shepard. Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S221–S354. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES